Mostrar el registro sencillo del ítem
dc.contributor.author
Takahashi, Yoshiko
dc.contributor.author
Avila, Susana
dc.contributor.author
Correa, Silvia
dc.contributor.author
Cardone, Karina
dc.contributor.author
Fernández, Mariana
dc.contributor.author
Crudo, Favio
dc.contributor.author
Sato, Miho
dc.contributor.author
Aiga, Hirotsugu
dc.contributor.author
Hirayama, Kenji
dc.contributor.author
Perez, Freddy
dc.contributor.author
Periago, Maria Victoria
dc.date.available
2025-01-03T15:39:47Z
dc.date.issued
2024-12
dc.identifier.citation
Takahashi, Yoshiko; Avila, Susana; Correa, Silvia; Cardone, Karina; Fernández, Mariana; et al.; Barriers and facilitators for preventing mother-to-child transmission of Trypanosoma cruzi and hepatitis B in the Gran Chaco region: A qualitative analysis using the consolidated framework for implementation research (CFIR); BioMed Central; BMC Primary Care; 25; 1; 12-2024; 1-10
dc.identifier.uri
http://hdl.handle.net/11336/251716
dc.description.abstract
Background Mother-to-child transmission (MTCT) of Trypanosoma cruzi and hepatitis B virus (HBV) increases morbidity and disability in Latin America and the Caribbean. The tailormade comprehensive antenatal care based on the Framework for the elimination of MTCT of HIV, syphilis, hepatitis B virus (HBV), and Chagas disease (EMTCT Plus) has been implemented in the region since 2018 through a private-public partnership. This study aimed to estimate the effectiveness of the intervention in preparing MTCT of T. cruzi and hepatitis B. The study further attempted to identify the barriers to and facilitators for preventing MTCT of T. cruzi and HBV in the Gran Chaco region of Argentina and Paraguay. Methods Data on T. cruzi and HBV screening and treatment among pregnant women and infants were collected from antenatal care (ANC) registries between June 2018 and December 2022. A cascade-of-care analysis was applied to assess the intervention’s effectiveness and identify bottlenecks. Additionally, key informant interviews were conducted for both implementors and service recipients to identify barriers to and facilitators for accessing screening and treatment using the Consolidated Framework for Implementation Research. Results A total of 1,658 pregnant women were recruited, achieving 100% antenatal care coverage and screening for T. cruzi and HBV. The prevalence of T. cruzi among pregnant women was 3.3% (95%CI: 2.4-4.1%), while in newborns it was 14.0% (95% CI: 6.0–25.0). Treatment coverage for newborns infected with T. cruzi was 100%, whereas postdelivery treatment coverage among mothers was 67.3%. This achievement was likely attributed to strong community engagement, contributing to 100% ANC coverage. However, barriers such as a fragile local health system, long-term follow-up requirements, high mobile populations, cultural beliefs, and social trauma were identified in target areas.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
BioMed Central
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.subject
TRYPANOSOMA CRUZI
dc.subject
CHAGAS DISEASE
dc.subject
HEPATITIS B
dc.subject
MOTHER-TO-CHILD TRANSMISSION
dc.subject
GRAN CHACO
dc.subject
PREGNANT WOMEN
dc.subject
EMTCT PLUS
dc.subject.classification
Ciencias Biomédicas Sociales
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Barriers and facilitators for preventing mother-to-child transmission of Trypanosoma cruzi and hepatitis B in the Gran Chaco region: A qualitative analysis using the consolidated framework for implementation research (CFIR)
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2025-01-03T11:56:01Z
dc.identifier.eissn
2731-4553
dc.journal.volume
25
dc.journal.number
1
dc.journal.pagination
1-10
dc.journal.pais
Reino Unido
dc.journal.ciudad
Londres
dc.description.fil
Fil: Takahashi, Yoshiko. Nagasaki University; Japón. Niigata University of Health and Welfare; Japón
dc.description.fil
Fil: Avila, Susana. Fundación Mundo Sano; Argentina
dc.description.fil
Fil: Correa, Silvia. Universidad Nacional de Salta; Argentina
dc.description.fil
Fil: Cardone, Karina. Fundación Mundo Sano; Argentina
dc.description.fil
Fil: Fernández, Mariana. Fundación Mundo Sano; Argentina
dc.description.fil
Fil: Crudo, Favio. Fundación Mundo Sano; Argentina
dc.description.fil
Fil: Sato, Miho. Nagasaki University; Japón
dc.description.fil
Fil: Aiga, Hirotsugu. Nagasaki University; Japón
dc.description.fil
Fil: Hirayama, Kenji. Nagasaki University; Japón
dc.description.fil
Fil: Perez, Freddy. Organizacion Mundial de la Salud; Argentina. Universidade Federal de Ciências da Saúde de Porto Alegre; Brasil
dc.description.fil
Fil: Periago, Maria Victoria. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fundación Mundo Sano; Argentina
dc.journal.title
BMC Primary Care
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://bmcprimcare.biomedcentral.com/articles/10.1186/s12875-024-02683-z
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1186/s12875-024-02683-z
Archivos asociados